Rheumatology-related drug safety, approvals, and what’s in the pipeline.
Opening a New Therapeutic Window for Rheumatoid Arthritis
New targets in rheumatoid arthritis: SYK, JAK, BTK
Drug Updates: Apremilast, Belimumab, and More
Information on new approvals and medication safety